What is impaired in the absence of von Willebrand factor (vWF), specifically regarding the adhesion of platelets to subendothelial collagen?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Platelet Adhesion to Subendothelial Collagen Requires von Willebrand Factor

The adhesion of platelets to subendothelial collagen is impaired in the absence of von Willebrand factor (option 1). This is the correct answer, as vWF serves as the essential bridge between exposed collagen and platelet receptors, particularly under high shear stress conditions.

Mechanism of vWF-Mediated Platelet Adhesion

von Willebrand factor plays a key role in primary hemostasis by mediating platelet adhesion to the subendothelium, especially at high shear rates that prevail in the microcirculation 1. The mechanism operates as follows:

  • vWF binds first to subendothelial collagen (particularly collagen VI) before platelet adhesion occurs 2. This binding occurs via the A1 domain of vWF 3.

  • Under high shear stress conditions (>1000 s⁻¹), vWF undergoes conformational changes from a globular to an unfolded state, exposing binding sites for platelet glycoprotein Ib (GPIb) 1. At low shear rates (<1000 s⁻¹), vWF circulates in a globular conformation that poorly interacts with platelets 1.

  • The high-molecular-weight (HMW) multimers of vWF (5500-10,000 kDa) are the most effective in promoting platelet adhesion under high shear rates at sites of vascular injury 1.

  • vWF forms a "bridge" between the platelet membrane (via GPIb/IX complex) and subendothelial collagen 2, 4.

Clinical Evidence from von Willebrand Disease

Patients with von Willebrand disease demonstrate markedly decreased platelet adhesion (57.3 ± 3.4% surface coverage) compared to normal subjects (83.3 ± 1.9%) 5. This adhesion defect is corrected by the addition of vWF 2.

Studies using monoclonal antibodies to vWF in normal blood confirm decreased platelet adhesion to subendothelium, validating vWF's essential role 2.

Why the Other Options Are Incorrect

  • Plasmin (option 2): This is a fibrinolytic enzyme that degrades fibrin clots; it does not mediate platelet adhesion to collagen.

  • Heparin (option 3): This is an anticoagulant that enhances antithrombin activity; it does not facilitate platelet adhesion.

  • Antithrombin III (option 4): This is a serine protease inhibitor that inactivates thrombin and other coagulation factors; it has no role in platelet adhesion to collagen.

Shear Rate Dependency

The importance of vWF in platelet adhesion is particularly pronounced under high shear conditions characteristic of arterial circulation 4, 3. At lower shear rates, direct platelet-collagen interactions via GPIIb-IIIa and α₂β₁ integrin receptors may partially compensate for vWF absence 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.